National Hospital Organisation Shikoku Cancer Centre Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2010
NCT01000896
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

National Hospital Organization Shikoku Cancer Center

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Ovarian Epithelial (Phase 1)

Colorectal Neoplasms (Phase 2)

Ovarian Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 8